Streetbeat News

Analyst Ratings

CF

RBC Capital analyst Andrew Wong has reiterated an Outperform rating on CF Industries Holdings (NYSE:CF) and maintained a $95 price target.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 2:18 pm

INTC

QCOM

Analyst Ming-Chi Kuo reports that Qualcomm has ceased development of chips for the Intel 20A node. This could negatively impact the learning curve of RibbonFET and PowerVia technologies, increasing uncertainty and risk for Intel 18A R&D and mass production. Qualcomm's decision may be due to increased development costs post-7nm and resource constraints.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 2:17 pm

GM

A significant bearish stance on General Motors (NYSE:GM) has been observed, with unusual options activity. The sentiment among big-money traders is split between 26% bullish and 73% bearish. Whales have been targeting a price range from $35.0 to $35.0 for GM over the last 3 months. The price of GM is currently down -2.35% at $36.22. Wells Fargo and Citigroup have maintained their Underweight and Buy ratings on GM respectively, while Benchmark has downgraded its action to Buy.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 2:16 pm

AMD

A whale investor has taken a bearish stance on Advanced Micro Devices (AMD), with 64% of recent trades being bearish. The targeted price range for AMD over the last 3 months has been $113.0 to $125.0. The current price of AMD is down 2.8% at $113.54. Analysts have mixed opinions, with ratings ranging from Neutral to Buy and price targets from $130 to $200.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 2:16 pm

CRWD

A significant number of investors have taken a bearish stance on CrowdStrike Holdings (NASDAQ:CRWD), with 63% of detected trades being bearish. The majority of these trades are puts, totaling $839,493, compared to $93,024 in calls. Whales have been targeting a price range from $70.0 to $200.0 for CrowdStrike over the last 3 months. The current price of CRWD is down -3.23% at $146.1. Analysts from Morgan Stanley maintain an Overweight rating with a price target of $178, while JMP Securities and Needham have downgraded their actions with price targets of $235 and $170 respectively.

Portfolio Pulse from Benzinga Insights

August 08, 2023 | 2:16 pm

AGI

RBC Capital analyst Michael Siperco has reiterated a 'Sector Perform' rating on Alamos Gold (NYSE:AGI) and maintained a $10 price target.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 2:16 pm

ADV

Goldman Sachs analyst Jason English has maintained a Neutral rating on Advantage Solutions (NASDAQ:ADV) and raised the price target from $2.9 to $3.3.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 2:14 pm

PLX

Zacks Small-Cap Research has set a price valuation of $16 for Protalix BioTherapeutics. This valuation could potentially influence the stock's performance in the short term.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 2:14 pm

VCTR

Morgan Stanley analyst Michael Cyprys has maintained an Underweight rating on Victory Capital Holdings (NASDAQ:VCTR) and raised the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 2:10 pm

WHD

Benchmark analyst Kurt Hallead has reiterated a 'Buy' rating on Cactus (NYSE:WHD) and maintained a price target of $60.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 2:10 pm